Invest in good fundamental will eventually be rewarded. With great Q2 results, Very soon Institutional players will slowly participate..

@Lisabell88, I don't have Supermax only have Careplus. But I think you can keep Supermax since is mainly OBM manufacturer. Their Q4 result out next month and I expect their results will be very good. The other 6 glove companies are mainly OEM and only Careplus is extremely undervalued. You can sell Kossan to switch to Careplus if you want.


Lisabell88 Thinking of selling supermax and Kossan units to buy in careplus. What you all think?
30/07/2020 9:47 AM

Lisabell88, depends on whether you believe glove demand still there and pandemic will not settle soon. If you do, current Careplus price is than cheap compare to the peer. I’d believe pandemic will not over so soon and therefore below 3.2 is still good buy.

@Gooner82, same though as me. I think base on additional average 1.5 new lines install per month from Q3 onwards. Average extra 5m per month for Q3 and 10m for Q4 is achievable

@Lisabell88. Careplus FY2020 production capacity is 6.2bn, share issue is 540m. Top glove is 86.2bn, share issued is 2,697m . Comfort is 5.2bn. share issue is 580m. Now glove is seller’s market. Do you think Careplus price should be lower than Comfort? market cap for careplus should be around 7% of Top Glove as the capacity is 7% of Top Glove . So, work out your own target price

karpai3, yes, Careglove is the 14 lines factory contribute the most PAT and mainly to Brazil.

Ansell is Number 1 Surgical supplier in the world. Currently CMSB contribute extremely low PAT not because CMSB is not efficient but is due to major modifications or upgrade to meet compliances like EN standard and etc so that CMSB meets the compliance to supply to Ansell existing customers. You can see from the CMSB account post JV, where the expenses is extra ordinary high. Net Margin only 6.8% where net margin for Careplus 100% owned is more than 25%

@air01557 At first i just ignored you. But you either pretend very smart or try to con the ignorant. I really cannot tahan you liao. FYI, up to June 2020 Careplus have total 28 lines in 3 factories. Ansell bought 50% Careplus (Malaysia) Sdn Bhd which have only 8 lines. Total profit contribution from CMSB is RM0.886m for period 15/5/20-30/6/20. For 1/4/20-14/5/20 is less than RM1.7m. So, even excluded100% CMSB PAT. CAREPLUS still have more than 18m core business PAT. Furthermore, Careplus will install another 9 lines for 2H FY2020. So, even without 100% CMSB, the PAT will still growing for Q3 and Q4.

@EngineeringProfit Careplus will lead Supermax by few horses not by nose length.

Why needs KYY if Invest IN Careplus? Is a no Brainer stock

@thesigncom, buy back careplus now or you may regret this afternoon

@SiLiaw good luck to you.

In March, My careplus TP is 1.62, After understand more about the company, My TP revised to 4. But, after seeing how other glove counters perform. I have no target price now.. Just hold till it burst

@EngineeringProfit, Do you know Supermax is actually Careplus NO 2? At 2.86, YTD Careplus already up 1682% which is from 0.17 to 2.86.


EngineeringProfit For those who rode SUPERMAX from 1.70 to 17.00 .................they can feel it

This is SUPERMAX no.2

AlanLW I understand Q2 revenue was good and sold 50% to Ansell Australia. I would like to know the next quarter Q3 Projected revenue will also need discounted 50% as Ansell Australia had bought 50% of Careplus Group Berhad

@ AlanLW, Ansell only bought 50% share of CMSB which currently has 8 lines. For Q2, only About 10%-15% of the core businees PAT came from CMSB. I guess So low due to upgrading works is currently going on. Q3 profit will not be affected much by CMSB and furthermore 9 new lines will run in from Q3 onwards.

TTD1990, PE = PRICE EARNING. Share Price/Annualized Earning Per share = PE or layman terms for PE is how many years the company needs to make the amount of profit equivalent to investment you invest.

@Ccm1517, please share right info! Careplus Q1 PAT was Rm1m+NOT RM5 .Q2 Core Profit after tax is RM20.9M. Increase of more than 20 times not 4.16 times.

@ thetruthoracle
As I said yesterday, Hotstuff is lonely and old sick man, just let him continue to bark here. This morning I though he has recover a bit. Apparently he is not.. God bless him

US detained Top Glove disposable and now Top Glove suspended. This has drag others panic sellers sell their glove stock irrationally. Just think who will benefits if Top Glove not allow to export to US? When you have an answer, then just think you should sell or buy more Careplus

For those have extra fund, just buy. For those no more bullets, just watch. After Q2 results out Watch also shiok..

Currently The cheapest valuation pending July Q2 results out is Careplus. At current price, even POST COVID still will be cheap after JV with Ansell. Invest in Share not speculate. Just buy in more when ever is in Red today. You will be shock with Exponential profit increase for Q2.

HEALTH AND SCIENCE
Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced ‘robust’ immune response
PUBLISHED TUE, JUL 14 20205:00 PM EDTUPDATED 3 HOURS AGO

American is now known as biggest liar, always published unconfirmed news to boost their share price

There always good shinning sky after bad weather. Won't be surprise to see a big drop before it starts moving up again. For those can't take pressure but still wants to stick to Careplus boat. Better don't look at the counter until end of July. haha

simple, don't switch on your screen. Start look at Careplus on 28th July

Those who thinks TG and Supermax everyday will goes up, they should bet all their assets in. Maybe by end of this or next year, the market caps will not only over take Maybank but Apple become the largest market cap in the world. Just wish them good luck..but don't come to lousy careplus forum to talk nonsense and wasting time.

Careplus always good for patient investors, loyal investors will be rewarded after Q2 results out by end of this month.

@z5spyglass Anything is possible, wish you extremely good luck...

@kk, Mr Lim declared intention to trade during closed period on 29th June, that means Q2 results will be out no later than 28th July or within 1 month

Careplus currently allocate 20-30% production capacities for 3-6 months contract Spot buyers , where the price are much higher

Mtrade, this is Careplus forum. Don't talk unrelated topic here. Go to Supermax Forum

Bacon, optimistic is good. But too optimistic become siok sendiri. Everyday you said limit up, if no drop consider lucky.

Cwscws, the 9m placed to affluent and institutional investors who are mainly holds long.

jinghee, too many good news. Just wait till the Q2 results out end of this month. Then you will know how good the news.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3066122

Many ignorant people don't understand how PP works. PP is 10% or 53m. The reason why only 10m PP was offered last month is due to management thinks Careplus share price still undervalued but the company needs about RM10m for lines expansion now. We shall expect much more PP placement post Q2 result (2nd phase PP should be in August) when the share price goes to more reasonable priced when that time both Investors and management think is reasonable.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3065870. he bought at 1.38 & 1.39

Quarter 1 report extend to before 15th July.

Not surprise Tan Sri buying. Sunway is really undervalued and ICPS offer is really attractive.

Vaccine news keep going out. Good news for collecting more

If a glove manufacturer is not needed after a vaccine is out. Then how Top Glove and Hartalega price around RM5-6 before COVID-19? Base on expansion plan and JV partner, Careplus is going to venture into higher value products segment and more production. Before Covid, Hartalega net profit margin is 14%, and Top Glove is 7%. At 8% margin, RM1.6 is reasonable price for careplus even before COVID. With Covid now, Careplus margin easily pass far beyond 20% net margin. Investment takes time, not overnight. Careplus is just catching up what it miss out. So, why hurry to sell even vaccine is going to roll out tomorrow? Wait for August quarter result which reflecting true effects of Covid.

@/secretinvestor8888 I see you posted in every forums calling people to sell Glove stocks. You miss out glove stock? Hoping others sell to you? Market always have plenty of sellers, just buy from there la.

@ secretinvestor8888 you sure?

Careplus best reporting will be for April-June which expected even better than 500% profit increase

Top Glove report profit 350m or 500% up. This is not full Covid effect yet as March pricing only increase a bit.

SGX S$6.04 already

TG results will be unbelievable good. You will know after lunch

TG result should be lunch time

sell now so that you can pick up?

Hotstuff, where is your brain? top or bottom? Sochai only hope other glove counters not performing when he claimed he has Top Glove. During this time, 1 glove company cannot perform means the others also won’t be good.

Hotstuff, only sochai will think others are sochai. If you have sold, why hang around here and keep asking others to sell and said those buy are sochai. You way to fish others to sell low are outdated. Your sochai method don't work here leh. Change another tactic la